🧬 Noam Solomon - Immunai - Part 2 | The Value of Attending Prestigious Institutions | Immunai’s Genesis | AI, Machine Learning, & Their Applications in the Life Sciences | Mapping the Human Immune System

episode

The Biotech Startups Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Can Toia Shut Herbie Down? Penrith's Vulnerable State & Moses' Lebanon Exit!| NRL Daily 47 min · 24 Sep 2026 · Triple M Rocks Footy NRL

Ask, Tell, Confess: I Can't Believe He CHEATED?! 31 min · 24 Sep 2026 · Dumb Blonde

NPR News: 09-23-2026 10PM EDT 4 min · 24 Sep 2026 · NPR News Now

10PM ET 09/23/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

Xi in Washington, US-China Trade Truce Extended, More 8 min · 24 Sep 2026 · Bloomberg News Now

Whateley in a Snapshot | Thursday (24.09.26) 6 min · 24 Sep 2026 · Whateley

Report any issue

Source

Recorded15 Aug 2024

Publisherfeeds.fame.so ↗

Handlerec:3386534

Show notes

Part 2 of 4. My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in